In our study, we observed that CK19 mRNA expression was elevated exclusively in the serum of pancreatic cancer patients and was positively correlated with systemic inflammation, as indicated by increased WBC and CRP levels, two commonly used clinical inflammatory markers. This evidence concerns the gene KRT19 and pancreatic neoplasm.